Anti-COVID drug ‘Colchicine’ cleared for phase 2 clinical trials
New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the…
New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the…
New Delhi: India and Sri Lanka have joined hands to scale up the genome surveillance for SARS-CoV-2 in the two countries…
New Delhi: Defence Research and Development Organisation (DRDO) scientists have now got a new breakthrough after developing COVID-19 drug 2-DG.…
New Delhi: PathShodh Healthcare, a start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc),…
New Delhi: Union Minister for Science and Technology, Earth Sciences and Health and Family Welfare, Dr Harsh Vardhanhas launched“AahaarKranti”, a…
New Delhi: Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) has inked a pact with SBI Foundation for CSR (corporate…
New Delhi: Currently, there are no universally approved drugs for the treatment of COVID-19. There is a worldwide scramble to…
New Delhi: The Council of Scientific and Industrial Research’s Bhopal-based Advanced Materials and Processes Research Institute (CSIR-AMPRI) has set up…
New Delhi: In a new health scare, a team of researchers from India, the UK and Russia, has found that…